Ann: US Patent Office Grants Key Risk Test Patent, page-7

News/updates for GTG could be anytime now.

"The next stage in the product development process will be to confirm and improve upon the initial observations as more patient data becomes available. On completion of that review of the additional patient data (anticipated over the next 30 days), the Company intends to seek CLIA registration of the product as a new polygenic risk score (PRS) test to predict an individual’s risk of developing life-threatening complications should they become infected with COVID-19."

https://www.globenewswire.com/news-release/2020/05/22/2037811/0/en/Genetic-Technologies-Provides-Operational-Update-Successful-Prototype-Polygenic-Risk-Score-for-COVID-19-Created.html